U.S. federal trademark · Serial No. 90562641
Diagnostic testing for the detection of cancer, namely, molecular testing intended to assess the presence or absence of residual disease at an individual's initial timepoint for hematologic cancer management
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.